Diagnostics and analysis of SARS-CoV-2: current status, recent

CRISPR–Cas12-based detection of SARS-CoV-2

Multiplex assays for the identification of serological signatures of SARS- CoV-2 infection: an antibody-based diagnostic and machine learning study - The Lancet Microbe

Frontiers Review of Current COVID-19 Diagnostics and Opportunities for Further Development

JCM, Free Full-Text

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives - Chemical Science (RSC Publishing) DOI:10.1039/D2SC06665C

Frontiers SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Characteristics of SARS-CoV-2 and COVID-19

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry - The Lancet Oncology

Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021

Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings - nCoV-2019 Genomic Epidemiology - Virological

Two Years into the COVID-19 Pandemic: Lessons Learned